Evaluating	O
clinical	O
,	O
dietary	B:C0012155
and	O
psychological	O
risk	O
factors	I:C0035648
for	O
relapse	O
of	O
ulcerative	O
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
.	O

Evaluating	O
clinical	O
,	O
dietary	O
and	O
psychological	O
risk	B:C0035648
factors	I:C0035648
for	O
relapse	O
of	O
ulcerative	O
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
.	O

Evaluating	O
clinical	O
,	O
dietary	O
and	O
psychological	O
risk	O
factors	I:C0035648
for	O
relapse	O
of	O
ulcerative	B:C0009324
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
.	O

Evaluating	O
clinical	O
,	O
dietary	O
and	O
psychological	O
risk	O
factors	I:C0035648
for	O
relapse	O
of	O
ulcerative	O
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	B:C0442418
and	O
histological	O
remission	O
.	O

The	O
literature	O
on	O
possible	O
factors	O
that	O
could	O
trigger	O
a	O
relapse	O
in	O
patients	O
with	O
ulcerative	B:C0009324
colitis	I:C0009324
(	O
ulcerative	O
colitis	I:C0009324
)	O
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
on	O
long	O
term	O
follow	O
up	I:C1522577
is	O
scarce	O
.	O

The	O
literature	O
on	O
possible	O
factors	O
that	O
could	O
trigger	O
a	O
relapse	O
in	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
(	O
ulcerative	B:C0009324
colitis	I:C0009324
)	O
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
on	O
long	O
term	O
follow	O
up	I:C1522577
is	O
scarce	O
.	O

The	O
literature	O
on	O
possible	O
factors	O
that	O
could	O
trigger	O
a	O
relapse	O
in	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
(	O
ulcerative	O
colitis	I:C0009324
)	O
in	O
clinical	O
,	O
endoscopic	B:C0442418
and	O
histological	O
remission	O
on	O
long	O
term	O
follow	O
up	I:C1522577
is	O
scarce	O
.	O

The	O
literature	O
on	O
possible	O
factors	O
that	O
could	O
trigger	O
a	O
relapse	O
in	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
(	O
ulcerative	O
colitis	I:C0009324
)	O
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
on	O
long	O
term	O
follow	B:C1522577
up	I:C1522577
is	O
scarce	O
.	O

To	O
determine	O
the	O
relapse	O
rate	O
in	O
patients	O
with	O
ulcerative	B:C0009324
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
and	O
identify	O
factors	O
that	O
may	O
influence	O
the	O
risk	O
of	O
relapse	O
.	O

To	O
determine	O
the	O
relapse	O
rate	O
in	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	B:C0442418
and	O
histological	O
remission	O
and	O
identify	O
factors	O
that	O
may	O
influence	O
the	O
risk	O
of	O
relapse	O
.	O

Patients	O
with	O
ulcerative	B:C0009324
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
were	O
enrolled	O
between	O
January	O
-	O
July	O
2010	O
and	O
followed	O
up	I:C1522577
for	O
1	O
year	O
to	O
determine	O
the	O
effect	O
of	O
clinical	O
,	O
dietary	O
and	O
psychological	O
factors	O
on	O
relapse	O
.	O

Patients	O
with	O
ulcerative	O
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	B:C0442418
and	O
histological	O
remission	O
were	O
enrolled	O
between	O
January	O
-	O
July	O
2010	O
and	O
followed	O
up	I:C1522577
for	O
1	O
year	O
to	O
determine	O
the	O
effect	O
of	O
clinical	O
,	O
dietary	O
and	O
psychological	O
factors	O
on	O
relapse	O
.	O

Patients	O
with	O
ulcerative	O
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
were	O
enrolled	O
between	O
January	O
-	O
July	O
2010	O
and	O
followed	B:C1522577
up	I:C1522577
for	O
1	O
year	O
to	O
determine	O
the	O
effect	O
of	O
clinical	O
,	O
dietary	O
and	O
psychological	O
factors	O
on	O
relapse	O
.	O

Patients	O
with	O
ulcerative	O
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
were	O
enrolled	O
between	O
January	O
-	O
July	O
2010	O
and	O
followed	O
up	I:C1522577
for	O
1	O
year	O
to	O
determine	O
the	O
effect	O
of	O
clinical	O
,	O
dietary	B:C0012155
and	O
psychological	O
factors	O
on	O
relapse	O
.	O

Patients	O
with	O
ulcerative	O
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
were	O
enrolled	O
between	O
January	O
-	O
July	O
2010	O
and	O
followed	O
up	I:C1522577
for	O
1	O
year	O
to	O
determine	O
the	O
effect	O
of	O
clinical	O
,	O
dietary	O
and	O
psychological	O
factors	B:C0035648
on	O
relapse	O
.	O

Information	O
regarding	O
factors	O
that	O
may	O
affect	O
relapse	O
such	O
as	O
infection	B:C3714514
,	O
antibiotic	O
or	O
NSAIDs	O
use	O
and	O
any	O
other	O
factor	O
which	O
the	O
patient	O
felt	O
important	O
,	O
and	O
compliance	O
with	O
medications	O
was	O
obtained	O
.	O

Information	O
regarding	O
factors	O
that	O
may	O
affect	O
relapse	O
such	O
as	O
infection	O
,	O
antibiotic	B:C0003232
or	O
NSAIDs	O
use	O
and	O
any	O
other	O
factor	O
which	O
the	O
patient	O
felt	O
important	O
,	O
and	O
compliance	O
with	O
medications	O
was	O
obtained	O
.	O

Information	O
regarding	O
factors	O
that	O
may	O
affect	O
relapse	O
such	O
as	O
infection	O
,	O
antibiotic	O
or	O
NSAIDs	B:C0003211
use	O
and	O
any	O
other	O
factor	O
which	O
the	O
patient	O
felt	O
important	O
,	O
and	O
compliance	O
with	O
medications	O
was	O
obtained	O
.	O

Information	O
regarding	O
factors	O
that	O
may	O
affect	O
relapse	O
such	O
as	O
infection	O
,	O
antibiotic	O
or	O
NSAIDs	O
use	O
and	O
any	O
other	O
factor	O
which	O
the	O
patient	O
felt	O
important	O
,	O
and	O
compliance	O
with	O
medications	B:C2081612
was	O
obtained	O
.	O

97	O
patients	O
(	O
59	O
males	B:C0025266
,	O
mean	O
age	O
39	O
+	O
11.9	O
years	O
)	O
were	O
followed	O
up	I:C1522577
for	O
a	O
mean	O
duration	O
of	O
9	O
+	O
2.3	O
months	O
.	O

97	O
patients	O
(	O
59	O
males	O
,	O
mean	O
age	O
39	O
+	O
11.9	O
years	O
)	O
were	O
followed	B:C1522577
up	I:C1522577
for	O
a	O
mean	O
duration	O
of	O
9	O
+	O
2.3	O
months	O
.	O

On	O
univariate	O
analysis	O
more	O
relapsers	O
had	O
significantly	O
higher	O
NSAIDs	B:C0003211
use	O
within	O
15	O
days	O
of	O
relapse	O
,	O
respiratory	O
tract	I:C0035243
infection	I:C0035243
within	O
4	O
weeks	O
,	O
use	O
of	O
steroids	O
more	O
than	O
once	O
in	O
past	O
,	O
higher	O
consumption	O
of	O
calcium	O
,	O
riboflavin	O
,	O
vitamin	O
A	I:C0042839
and	O
lower	O
consumption	O
of	O
sugars	O
.	O

On	O
univariate	O
analysis	O
more	O
relapsers	O
had	O
significantly	O
higher	O
NSAIDs	O
use	O
within	O
15	O
days	O
of	O
relapse	O
,	O
respiratory	B:C0035243
tract	I:C0035243
infection	I:C0035243
within	O
4	O
weeks	O
,	O
use	O
of	O
steroids	O
more	O
than	O
once	O
in	O
past	O
,	O
higher	O
consumption	O
of	O
calcium	O
,	O
riboflavin	O
,	O
vitamin	O
A	I:C0042839
and	O
lower	O
consumption	O
of	O
sugars	O
.	O

On	O
univariate	O
analysis	O
more	O
relapsers	O
had	O
significantly	O
higher	O
NSAIDs	O
use	O
within	O
15	O
days	O
of	O
relapse	O
,	O
respiratory	O
tract	I:C0035243
infection	I:C0035243
within	O
4	O
weeks	O
,	O
use	O
of	O
steroids	B:C0038317
more	O
than	O
once	O
in	O
past	O
,	O
higher	O
consumption	O
of	O
calcium	O
,	O
riboflavin	O
,	O
vitamin	O
A	I:C0042839
and	O
lower	O
consumption	O
of	O
sugars	O
.	O

On	O
univariate	O
analysis	O
more	O
relapsers	O
had	O
significantly	O
higher	O
NSAIDs	O
use	O
within	O
15	O
days	O
of	O
relapse	O
,	O
respiratory	O
tract	I:C0035243
infection	I:C0035243
within	O
4	O
weeks	O
,	O
use	O
of	O
steroids	O
more	O
than	O
once	O
in	O
past	O
,	O
higher	O
consumption	B:C1947907
of	O
calcium	O
,	O
riboflavin	O
,	O
vitamin	O
A	I:C0042839
and	O
lower	O
consumption	O
of	O
sugars	O
.	O

On	O
univariate	O
analysis	O
more	O
relapsers	O
had	O
significantly	O
higher	O
NSAIDs	O
use	O
within	O
15	O
days	O
of	O
relapse	O
,	O
respiratory	O
tract	I:C0035243
infection	I:C0035243
within	O
4	O
weeks	O
,	O
use	O
of	O
steroids	O
more	O
than	O
once	O
in	O
past	O
,	O
higher	O
consumption	O
of	O
calcium	B:C0006675
,	O
riboflavin	O
,	O
vitamin	O
A	I:C0042839
and	O
lower	O
consumption	O
of	O
sugars	O
.	O

On	O
univariate	O
analysis	O
more	O
relapsers	O
had	O
significantly	O
higher	O
NSAIDs	O
use	O
within	O
15	O
days	O
of	O
relapse	O
,	O
respiratory	O
tract	I:C0035243
infection	I:C0035243
within	O
4	O
weeks	O
,	O
use	O
of	O
steroids	O
more	O
than	O
once	O
in	O
past	O
,	O
higher	O
consumption	O
of	O
calcium	O
,	O
riboflavin	B:C0035527
,	O
vitamin	O
A	I:C0042839
and	O
lower	O
consumption	O
of	O
sugars	O
.	O

On	O
univariate	O
analysis	O
more	O
relapsers	O
had	O
significantly	O
higher	O
NSAIDs	O
use	O
within	O
15	O
days	O
of	O
relapse	O
,	O
respiratory	O
tract	I:C0035243
infection	I:C0035243
within	O
4	O
weeks	O
,	O
use	O
of	O
steroids	O
more	O
than	O
once	O
in	O
past	O
,	O
higher	O
consumption	O
of	O
calcium	O
,	O
riboflavin	O
,	O
vitamin	B:C0042839
A	I:C0042839
and	O
lower	O
consumption	O
of	O
sugars	O
.	O

On	O
univariate	O
analysis	O
more	O
relapsers	O
had	O
significantly	O
higher	O
NSAIDs	O
use	O
within	O
15	O
days	O
of	O
relapse	O
,	O
respiratory	O
tract	I:C0035243
infection	I:C0035243
within	O
4	O
weeks	O
,	O
use	O
of	O
steroids	O
more	O
than	O
once	O
in	O
past	O
,	O
higher	O
consumption	O
of	O
calcium	O
,	O
riboflavin	O
,	O
vitamin	O
A	I:C0042839
and	O
lower	O
consumption	B:C1947907
of	O
sugars	O
.	O

On	O
univariate	O
analysis	O
more	O
relapsers	O
had	O
significantly	O
higher	O
NSAIDs	O
use	O
within	O
15	O
days	O
of	O
relapse	O
,	O
respiratory	O
tract	I:C0035243
infection	I:C0035243
within	O
4	O
weeks	O
,	O
use	O
of	O
steroids	O
more	O
than	O
once	O
in	O
past	O
,	O
higher	O
consumption	O
of	O
calcium	O
,	O
riboflavin	O
,	O
vitamin	O
A	I:C0042839
and	O
lower	O
consumption	O
of	O
sugars	B:C0242209
.	O

On	O
multivariate	O
analysis	O
,	O
NSAIDs	B:C0003211
use	O
[	O
HR	O
(	O
95	O
%CI	O
)	O
:	O
6.41(	O
1.88-21.9	O
)	O
]	O
and	O
intake	O
of	O
Vitamin	O
A	I:C0042839
[	O
HR	O
(	O
95	O
%CI	O
)	O
:	O
1.008	O
(	O
1.000	O
-	O
1.016	O
)	O
]	O
were	O
statistically	O
significant	O
predictors	O
of	O
relapse	O
.	O

On	O
multivariate	O
analysis	O
,	O
NSAIDs	O
use	O
[	O
HR	O
(	O
95	O
%CI	O
)	O
:	O
6.41(	O
1.88-21.9	O
)	O
]	O
and	O
intake	O
of	O
Vitamin	B:C0042839
A	I:C0042839
[	O
HR	O
(	O
95	O
%CI	O
)	O
:	O
1.008	O
(	O
1.000	O
-	O
1.016	O
)	O
]	O
were	O
statistically	O
significant	O
predictors	O
of	O
relapse	O
.	O

With	O
a	O
relapse	O
rate	O
of	O
18.6	O
%	O
over	O
a	O
follow	B:C1522577
up	I:C1522577
of	O
9	O
months	O
in	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
,	O
independent	O
predictors	O
of	O
relapse	O
were	O
history	O
of	O
NSAIDs	O
use	O
within	O
15	O
days	O
of	O
relapse	O
and	O
higher	O
intake	O
of	O
Vitamin	O
A	I:C0042839
.	O

With	O
a	O
relapse	O
rate	O
of	O
18.6	O
%	O
over	O
a	O
follow	O
up	I:C1522577
of	O
9	O
months	O
in	O
patients	O
with	O
ulcerative	B:C0009324
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
,	O
independent	O
predictors	O
of	O
relapse	O
were	O
history	O
of	O
NSAIDs	O
use	O
within	O
15	O
days	O
of	O
relapse	O
and	O
higher	O
intake	O
of	O
Vitamin	O
A	I:C0042839
.	O

With	O
a	O
relapse	O
rate	O
of	O
18.6	O
%	O
over	O
a	O
follow	O
up	I:C1522577
of	O
9	O
months	O
in	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	B:C0442418
and	O
histological	O
remission	O
,	O
independent	O
predictors	O
of	O
relapse	O
were	O
history	O
of	O
NSAIDs	O
use	O
within	O
15	O
days	O
of	O
relapse	O
and	O
higher	O
intake	O
of	O
Vitamin	O
A	I:C0042839
.	O

With	O
a	O
relapse	O
rate	O
of	O
18.6	O
%	O
over	O
a	O
follow	O
up	I:C1522577
of	O
9	O
months	O
in	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
,	O
independent	O
predictors	O
of	O
relapse	O
were	O
history	O
of	O
NSAIDs	B:C0003211
use	O
within	O
15	O
days	O
of	O
relapse	O
and	O
higher	O
intake	O
of	O
Vitamin	O
A	I:C0042839
.	O

With	O
a	O
relapse	O
rate	O
of	O
18.6	O
%	O
over	O
a	O
follow	O
up	I:C1522577
of	O
9	O
months	O
in	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
in	O
clinical	O
,	O
endoscopic	O
and	O
histological	O
remission	O
,	O
independent	O
predictors	O
of	O
relapse	O
were	O
history	O
of	O
NSAIDs	O
use	O
within	O
15	O
days	O
of	O
relapse	O
and	O
higher	O
intake	O
of	O
Vitamin	B:C0042839
A	I:C0042839
.	O

